https://www.selleckchem.com/products/BIBF1120.html
ean version of the Western Ontario and McMaster Universities Osteoarthritis Index, the EuroQol 5-Dimension 5-Level, and the doses of the rescue drug taken will be evaluated at baseline (1W) and weeks 2 (2W), 4 (4W), 6 (6W), and 8 (8W). The primary efficacy endpoint is the mean change in visual analogue scale at week 4 (4W) compared to baseline. Adverse events will be assessed at every visit. This study will provide useful data for evaluating the clinical efficacy and safety of TEA and electroacupuncture combination treatment for improv
Like
Comment
Share
